Top Pharma Companies in Asia

List of Top Pharma Companies in Asia – Asia is well known for the dynamic nature of its markets and its rapid growth. The pharmaceutical sector of the health care industry in Asia has seen strong growth in recent years. Southeast Asia alone is expected to generate $40 billion in pharmaceutical sales by 2020. The Asia Pacific is the third-largest pharmaceutical market in the world after North America and Europe, with generics being the major driver for the pharmaceutical industry in this region. Below given is the List of Top Pharma Companies in Asia.
The pharmaceutical market’s expansion will be driven by more than the region’s healthy GDP growth. Increasing populations, aging societies, political pressure to expand healthcare services, the growing proportion of newly disposable income that will be spent on health—will all lead to more drug purchases. In addition, less healthy lifestyles have led to an increase in costly, chronic disorders, such as cardiovascular disease and diabetes. To meet these growing needs, governments are making long-term investments in their health infrastructures.
BMI’s pharmaceutical expenditure forecasts show that, in general, developing countries will see a higher rate of pharmaceutical sales growth, while the growth for developed countries is lower. Countries that will experience strong growth include Vietnam (16.4%), China (15.0%), Sri Lanka (12.4%), Myanmar (12.2%) and Bangladesh (11.5%). Indonesia, for example, launched an ambitious plan to extend health care coverage to 100% of its population (nearly 240 million citizens) by 2019.
Top Pharma Companies in Asia
Stay with us to know more about Pharma Companies in Asia. Down in this article, we have provided the details about some of the Top leading Pharma Companies in Asia with their registered address and some of their famous product lists.
- Kalbe Farma’s
- Hyphens Pharma
- Takeda Pharmaceutical Company Limited
- Livzon Pharmaceutical Group Inc
- Shanghai Fosun Pharmaceutical
- Sun Pharmaceutical Industries Ltd
1. Kalbe Farma’s:
Kalbe established in the year 1966. The company has gone a long way from a humble operation that started in a garage to become the leading pharmaceutical company in Asia. In the international market, the Company has established its footprint in ASEAN countries, Nigeria, and South Africa, positioning Kalbe as a national pharmaceutical company with a competitive edge in the export market.
Kalbe Farma has established a robust research and development activities in leading-edge generic drug formulation and continuous development of innovative consumer and nutritional products. Kalbe Farma is also the largest publicly-listed pharmaceutical company in Southeast Asia, commanding a market capitalization of Rp71 trillion and sales turnover Rp21 trillion by the end of 2018. The product list includes:
- BRAINACT
- BROADCED
- CEFSPAN
- CERNEVIT
- Neuralgin RX
- NEUROTAM
- Cerebrofort Gold
- CEREBROVIT
- EXTRA JOSS
- H2 HEALTH & HAPPINESS
- Hydro Coco
- Komix Adult
- Komix Kid
- LOVE JUICE
- Mixagrip
- Promag Gazero
- Sakatonik ABC
- Sakatonik Liver
Established Year | 1966 |
GST No. | NA |
Drug License | Yes |
Product Range | NA |
Major Categories | Prescription drugs, over-the-counter (OTC) drugs, nutritional products, and supplements. |
Total No. of Employees | 13.2 thousand |
Managing Director | Vidjongtius. |
Contact them – Jl. Let. Jend Suprapto Kav 4 Jakarta 10510 – Indonesia
2. Hyphens Pharma:
Hyphens Pharma focuses on the sales and marketing of specialty pharmaceutical products in selected ASEAN countries through exclusive distributorship or licensing and supply agreements with brand principals mainly from Europe and the United States. They bring in specialty pharmaceutical products around these areas such as dermatology, pediatrics and neonatology, allergy, otorhinolaryngology (ear, nose, and throat), orthopedic and rheumatology, radiology, cardiology, and interventional cardiology and family medicine.
ASEAN is a growing market with more than 600 million people. With a rising middle-income group, it is the third-most populous region in the world, after South Asia and East Asia. According to a 2018 White Paper by Solidance, the total healthcare spending for six major ASEAN economies – Singapore, Malaysia, Vietnam, Indonesia, the Philippines, and Thailand – is forecasted to rise to USD 740 billion (2025) from USD 420 billion (2017). The product list includes:
- Besivance®
- BicoldTM
- BioFreedom
- BioMatrix Flex
- Ceradan®
- Cetraxal®
- Cetraxal® Plus
- TDF® Derma Formula
- Curosurf®
- D-Cure®
- Dorithricin®
- Dotarem®
- DuoxalTM
- D-Vita
- Ebixa®
- High Strength Omega-3
- Fenosup® Lidose®
- Fluanxol®
Established Year | 1998 |
GST No. | 06AHKPB1437H1ZP |
Drug License | Yes |
Product Range | 30 products |
Major Categories | Dermatology, Health supplements, Specialty pharmaceutical products, Other products. |
Total No. of Employees | between 201 and 500 |
Managing Director | See Wah |
Contact them – 16 Tai Seng Street, Level 4 Singapore 534138
3. Takeda Pharmaceutical Company Limited:
Takeda continues its transformation into an agile and innovative global pharmaceutical leader, serving the needs of patients and physicians worldwide. The company is a patient-focused, innovation-driven global pharmaceutical company that builds on a distinguished 235-year history, aspiring to bring better health and a brighter future for people worldwide. A 200 crore Company, Zydus Takeda are proud to stand high as a Quality conscious API manufacturer with utmost importance to SAFETY & Effluent Treatment of our waste.
The product list includes:
- Aprindine Hydrochloride Antiarrhythmic
- Bamifylline Hydrochloride Bronchodilator
- Ethamivan CNS Stimulant
- Lornoxicam Analgesic / Anti-inflammatory
- Pantoprazole Sodium Sesquihydrate Anti Ulcerant
- Podophyllotoxin Antineoplastic
- Policresulen Antiseptic
- Sulfametrole Antibacterial
- Suxamethonium Chloride Dihydrate Skeletal Muscle Relaxant
- Urapidil Antihypertensive
- Urapidil Hydrochloride
Established Year | 1925 |
GST No. | 27AADCT7273J1ZW |
Drug License | Yes |
Product Range | 55 drugs |
Major Categories | Gastrointestinal and inflammation, Rare diseases, Plasma-derived therapies, Oncology, Neuroscience, Vaccines. |
Total No. of Employees | 49,578 |
Managing Director | Gopal Agrawal, Anoop Kishore Kamat, Rajesh Eric Dmellokamath and Serina Magner Fischer. |
Contact them – 1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo 103-8668, Japan
4. Livzon Pharmaceutical Group Inc.:
Livzon Pharmaceutical Group Inc. established in the year 1985. The company is a comprehensive pharmaceutical enterprise integrating development & research, production and sales of pharmaceutical products. Livzon has 9 GMP production plants located in Guangdong, Shanghai, Sichuan, Fujian, 3 plantation bases for Chinese drug preparation production located in Shanxi, Gansu, Yunan of China, with more than 5,700 employees.
Livzon has modern industrial chain and product group, operates to manufacture drug preparation, bulk medicines, and intermediates, as well as diagnostic reagents and equipment, with approximate 280 products therapeutically grouped as the gastrointestinal, cardio-cerebral-vascular, anti-biotic, gonadotropic hormone, etc. Meanwhile, Livzon possesses production bases as the leading manufacturer of Chinese drug preparation injection, and specialist bulk medicines and intermediates such as fermented antibiotics, sterile cephalosporins, and hypolipidemic “statins”.
The product list includes:
- Urofollitropin for Injection
- Human Chorionic Gonadotrophin for Injection
- Leuprorelin Acetate Microspheres for Injection.
- Valaciclovir Hydrochloride Tablets.
- Mouse nerve growth factor for Injection
- Ranitidine Bismuth Citrate Tablets
- Menotropins for Injection
- Fluvoxamine Maleate Tablet
- Perospirone Hydrochloride Tablets
- Bismuth Potassium Citrate Capsules
- Live Bifidobacteriimi Preparation Oral
- Omeprazole Sodium for Injection
- Ranitidine Bismuth Citrate Capsules
- Ranitidine Bismuth Citrate Tablets
- Bismuth Potassium Citrate Tablets
Established Year | 1985 |
GST No. | 23AAFCL8283N1ZY |
Drug License | Yes |
Product Range | 18 |
Major Categories | APIs, Excipients, Diagnostic kits, Injections, Tablets, Suppositories. |
Total No. of Employees | 8,920 |
Managing Director | Tang Yanggang, Xu Guoxiang, Si Yanxia, Zhu Baoguo, Yu Xuan Huang, Vineet Lekhwani. |
Contact them – No.38, Chuangye Road North, Jinwan, Zhuhai, Guangdong, P.R.China, 519090
5. Shanghai Fosun Pharmaceutical:
Shanghai Fosun Pharmaceutical established in the year 1994. Adhering to the mission of improving human health, Fosun Pharma’s business covers all key sectors of healthcare industry chain, including pharmaceutical manufacturing and R&D, healthcare services, medical devices and medical diagnosis, as well as pharmaceutical distribution and retail, with pharmaceutical manufacturing and R&D as the core, and healthcare services as the development focus.
Fosun Pharma regards innovation, research, and development as the core driving factor of development and has developed an international R&D team in China, the United States., India and etc., and established innovative chemical drugs platforms, biologics platform, high-value generic drugs platform, and cell-therapy platform. The product list includes:
- Meglumine Adenosine Cyclophsphate Injection
- Alprostadil Dried Emulsion for Injection
- Low-molecular-weight Heparin Sodium for injection
- Dobesilate capsules
- Hemo-coagulase for Injection
- Deproteinised Calf Blood Injection
- Quetiapine Fumarate Tablets
- Artesunate for injection
- Rifampicin capsules
- Flucloxacillin Sodium for Injection
- Telmisartan
- Artesunate for injection
Established Year | 1994 |
GST No. | NA |
Drug License | Yes |
Product Range | 70 |
Major Categories | Pharmaceutical manufacturing, Medical devices, COVID-19 vaccines, Anti-infection products, Other products. |
Total No. of Employees | 40,370 |
Managing Director | Wang Kexin. |
Contact them – No. 1289 Yishan Road (Building A, Fosun Technology Park), Shanghai City
6. Sun Pharmaceutical Industries Ltd.:
Sun Pharmaceutical Industries Limited is an Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra that manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients (APIs) primarily in India and the United States. The company offers formulations in various therapeutic areas, such as cardiology, psychiatry, neurology, gastroenterology, and diabetology.
The Indian pharmaceutical industry has become the third-largest producer in the world in terms of volumes and is poised to grow into an industry of $20 billion in 2015 from the current turnover of $12 billion.
- AB PHYLLINE SR 200
- ABZORB DUSTING POWDER
- ACOSTIN INJ 1 MIU
- ACROTAC CAPS 25 MG
- AMIVAL TABLETS. 50MG
- Acamprosate Calcium
- Adefovir Dipivoxil
- Amifostine Trihydrate
- Atorvastatin Calcium Amorphous
- Atorvastatin Calcium Crystalline
- Benazepril Hydrochloride
- Bosentan Monohydrate
- Clarithromycin Granules 27.5%
- Citalopram Hydrobromide
- ADDWIZE 10MG 10 TAB
Established Year | 1983 |
GST No. | 03AADCS3124K2ZM. |
Drug License | Yes |
Product Range | 2000 products |
Major Categories | Generics, branded generics, specialty, difficult-to-make technology-intensive products, over-the-counter (OTC), antiretrovirals, etc. |
Total No. of Employees | 41,000 |
Managing Director | Dilip Shanghvi |
Contact them – 20th Floor, Jawahar Vyapar Bhawan, Tolstoy Marg New Delhi – 110001 INDIA
Conclusion:
I hope the information about the list of Top Pharma Companies in Asia in this article is useful for the readers, For more contact us.
Frequently Asked Questions About Top Pharma Companies in Asia
Q1. What are the factors contributing to the growth of the pharmaceutical sector in Asia?
Ans. The pharmaceutical sector in Asia is experiencing robust growth due to factors such as increasing populations, aging societies, political pressure to expand healthcare services, and the growing proportion of disposable income spent on health.
Q2. What are the major product categories offered by these pharmaceutical companies?
Ans. The major product categories offered by these pharmaceutical companies include prescription drugs, over-the-counter (OTC) drugs, nutritional products, supplements, dermatology products, pediatric and neonatal products, allergy medications, and specialty pharmaceutical products.
Q3. How is the pharmaceutical market expected to evolve in the coming years in Asia?
Ans. The pharmaceutical market in Asia is expected to witness continued growth, especially in developing countries such as Vietnam, China, Sri Lanka, Myanmar, and Bangladesh. With increased healthcare spending, rising middle-income groups, and a focus on innovation, the pharmaceutical market in Asia is poised for further expansion.

Hi, I am Aditi. I have a Degree in M.SC. Biotech. I love to write content related to the Pharmaceutical industry. I have been writing content related to the pharmaceutical industry for the past 5 years. I also have a work experience of more than 3 years as a research scientist. Linkedin Profile